explore -WSS

explore

author：leisure time 2025-09-30 18:53:58 - browse：5

An eye emerges from lines of binary codes — health tech coverage from STAT — Adobe

Investors are starting to back startups that offer privacy and security services to bolster health AI products already on the market while they wait for crucial safety and privacy regulations to take shape.

Though health leaders are racing to deploy generative AI products that can automatically transcribe doctor-patient conversations during medical appointments or churn through massive repositories of scientific research, they’re still flummoxed about how to measure their quality. Cybersecurity experts have warned that indiscriminately hooking third-party apps up to health system networks could expose sensitive data to hackers as ransomware attacks surge, and regulators and industry groups are rushing to set standards for responsible AI use.

Several government agencies and industry groups are working on rules and recommendations for avoiding bias and safety hazards within medical AI, but hospitals and startups are still in the dark about what exactly those will require and who’ll eventually be liable for any harm caused. It could be months, or even years, before these overlapping rules from multiple federal agencies are in place, and those rules might still change as the technology evolves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： TikTok, Instagram influencers need more rules for drug ads

WSS

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

HPV vaccine, cervical cancer study delivers historic results

Pumping milk in bathrooms at health conferences is common

HPV vaccine, cervical cancer study delivers historic results

Medicare drug price lawsuits could be good politics for Biden

Medicare drug price lawsuits could be good politics for Biden

focus

explore

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

DIEP, the 'gold standard' of breast reconstruction, is under threat

A pediatrician calls for Congress to pass the child tax credit deal

Dobbs anniversary: the lost opportunity of abortion as health care

Microsoft launches AI tool for clinical documentation through Epic

Medicare details structure of new drug price negotiation program

Update the Apgar Score to remove skin color

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA's Woodcock to retire early next year

focus

Medicare drug price lawsuits could be good politics for Biden

High breast density mammograms need follow

There's an unseen cost to disruptive road

Prior authorization reform is both possible and imperative

There's an unseen cost to disruptive road

Morphosys mixed study results for blood cancer drug

focus

explore

focus

explore